Glasgow adult centre
The centre develops, leads and delivers clinical and translational programmes focusing on early phase trials in solid tumours and haemato-oncology, spanning commercial and non-commercial studies.
Centre overview
Our Glasgow adult experimental cancer medicine centre (ECMC) works closely with discovery scientists in academic institutions, pharma and biotech partners, Cancer Research UK’s Centre for Drug Development and Blood Cancer UK’s Trial Acceleration Programme.
The centre has strengths in preclinical and phase 1 drug development, histology-independent and basket trials, tumour-focused early phase studies in:
colorectal cancer
hepato-biliary cancer
pancreatic cancer
ovarian cancer
urological cancer
neuro-oncology cancer
melanoma cancer
haemato-oncology studies (particularly chronic myeloid leukaemia, cell therapies and in the teenage and young adult population)
All trials are underpinned by precision medicine, pharmacodynamic biomarker studies and rich tissue‑based translational research, particularly translational immunology, molecular pathology and spatial biology. This has driven UK and international collaboration.
There is also a paediatric centre in Glasgow.
Expertise
gastrointestinal cancer (colorectal, pancreatic and hepatocellular carcinoma)
ovarian cancer
neuro-oncology (particularly glioblastoma)
haemato-oncology (especially chronic myeloid leukaemia and teenage and young adult)
biomarkers with a focus on translational immunology and molecular pathology
melanoma, including cell therapy studies
chemo-radiotherapy studies
precision medicine
Key contacts
Jeff Evans - Centre lead
Jeff Evans is Professor of Translational Cancer Research at the University of Glasgow and Honorary Consultant in Medical Oncology at the Beatson West of Scotland Cancer Centre. Jeff leads pre-clinical and clinical development of novel anti-cancer agents, with specific expertise in phase 1 clinical trials and in trials of hepatocellular carcinoma, gastro-oesophageal and pancreatic cancers.
Carol Evans - Centre business lead / Patient and public involvement co-lead
Carol Evans has held several trial coordination and project management roles, specialising in early-phase cancer clinical trials. Carol is the Glasgow Adult ECMC Project Manager, supporting the delivery of pan-Scotland objectives, including the Molecular Tumour Board. As the Centre Business Lead, Carol maintains oversight of the early phase trials portfolio.
Karen Bell - Patient and public involvement co-lead
Karen Bell is the NHS Research Scotland Cancer Research Network Manager for the West of Scotland with a nursing background, specialising in research and clinical trials. Karen oversees the support and development of the West of Scotland clinical cancer research patient and public involvement panel, that shaping activity across the regional clinical and translational cancer research landscape.
Contact details
Beatson West of Scotland Cancer Centre 1053 Great Western Road Glasgow G12 OYN | Queen Elizabeth University Hospital 1345 Govan Road Glasgow G51 4TF |
University of Glasgow Wolfson-Wohl Cancer Research Centre Garscube Estate Switchback Road Glasgow G61 1QH | Cancer Research UK Scotland Institute Garscube Estate Switchback Road Glasgow G61 1BD |
Centre email:
ggc.glasgowecmc@ggc.scot.nhs.uk
Programme office email:
You might also be interested in
Latest news
Explore the latest articles, updates, interviews and news from our network.
Sign up to our newsletter
Be the first to hear about the latest network news, events and opportunities with our monthly newsletter.
Industry and partners
We are a centralised platform for commercial partners to launch trials quickly with access to expert teams, sites and processes.